DBT
ENTA icon

Dubuque Bank & Trust’s Enanta Pharmaceuticals ENTA Stock Holding History

Dubuque Bank & Trust’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-170
Closed -$16K – 301
2019
Q1 		$16K Buy
170
+100
+143% +$8.97K ﹤0.01% 407
2018
Q4 		$5K Buy
+70
New +$5.37K ﹤0.01% 506

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dubuque Bank & Trust's ENTA Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of Enanta Pharmaceuticals (ENTA) in Q2 2019, closing a stake of 170 shares — an estimated $16K sold.

Dubuque Bank & Trust first reported a position in ENTA in Q4 2018 and held it in 2 quarters. The position peaked at $16K in Q1 2019. 194 funds tracked by Wall St. Rank hold ENTA as of Q2 2019.

  • Dubuque Bank & Trust reported no remaining Enanta Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Dubuque Bank & Trust sold 170 Enanta Pharmaceuticals shares in Q2 2019, an estimated $16K.
  • Dubuque Bank & Trust first reported a position in Enanta Pharmaceuticals in Q4 2018 and held it in 2 quarters.
  • Dubuque Bank & Trust's Enanta Pharmaceuticals position peaked at $16K in Q1 2019.
  • 194 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.